All Participants | Month | SCQ | EORTC QLQ-C30 | CR29 EORTC QLQ | EQ-5D-5L | MSKCC BFI | LARS | FCRI-SF | Questions Response efficacy | CaSUN |
---|---|---|---|---|---|---|---|---|---|---|
Screening visit | Â | X | X | X | X | X | X | X | Â | Â |
Chemoradiotherapy | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Run-in phase | Â | X | X | X | X | X | X | X | Â | Â |
Allocation visit | 0 | Â | Â | Â | Â | Â | Â | Â | Â | Â |
12-month visit | 12 | X | X | X | X | X* | X* | X | X | X |
24-months visit | 24 | X | X | X | X | X* | X* | X | X | X |